Changes in the natural course of Trypanosoma cruzi infection have been associated with immunosuppression. We report here a case of the reactivation of Chagas' disease in a patient with non-Hodgkin's lymphoma with gastric, oesophageal and laryngeal involvement. This is the first report describing the involvement of the larynx by T. cruzi.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.trstmh.2005.07.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expression patterns of Galectin-3 and NLRP3 in Chagas reactivation and graft damage in heart transplants.
Transpl Immunol
December 2024
Graduate Program in Health Sciences, Faculdade de Medicina de São José de Rio Preto (FAMERP), São José do Rio Preto, SP 15090-000, Brazil; Universidade de Ribeirão Preto (UNAERP), Ribeirão Preto, SP 14096-900, Brazil.
Objective: This study aimed to assess the expression patterns of galectin-3 (Gal-3) and NLRP3 in heart transplant recipients according to the presence of reactivated Trypanosoma cruzi infection or allograft rejection in Chagas and non-Chagas heart transplant recipients.
Methods: Gal-3 and NLRP3 expression levels were analyzed in endomyocardial biopsies from 31 heart transplant recipients, including 16 patients with chronic Chagas disease (ChD) and 15 without ChD. Samples were evaluated during periods of graft rejection or ChD reactivation, characterized by intense myocardial cellular infiltrate, and after remission of the infiltrate, classified by histopathological severity.
Prevalence of Infection in Solid Organ Transplant Recipients: A Neglected Disease in America.
Open Forum Infect Dis
December 2024
Department of Pharmacology & Toxicology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Article Synopsis
- This study examines the increase in infection prevalence among solid organ transplant recipients in the U.S. from 2019 to 2023 before their transplants.
- Researchers found a seroprevalence rate of 4.8% among 1,523 transplant candidates, with higher rates noted in lung and heart transplant recipients.
- The results emphasize the importance of enhancing screening methods for this overlooked tropical disease in transplant patients.
Concomitant diagnosis of Trypanosoma cruzi and HIV in a patient with neurologic manifestations: A case report.
Braz J Infect Dis
December 2024
Departamento de Parasitología, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica; Centro de Investigación en Enfermedades Tropicales (CIET), Universidad de Costa Rica, San José, Costa Rica. Electronic address:
American trypanosomiasis or Chagas disease is a vector-borne infection caused by the protozoan parasite Trypanosoma cruzi, characterized by acute and chronic phases; reactivations due to immunosuppression can occur. In this case report, we confirm the presence of trypomastigotes of T. cruzi in a patient with neurologic manifestations.
View Article and Find Full Text PDFAdvancements in LAMP-Based Diagnostics: Emerging Techniques and Applications in Viral Detection with a Focus on Herpesviruses in Transplant Patient Management.
Int J Mol Sci
October 2024
Laboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Article Synopsis
- - LAMP (Loop-mediated isothermal amplification) is a fast and effective method for diagnosing diseases, especially useful in point-of-care settings, and has evolved with adaptations for multiplex detection, allowing for testing multiple targets simultaneously.
- - The technique gained popularity during the COVID-19 pandemic for diagnosing various viruses, but there is limited research on its effectiveness in detecting Herpesviridae, which are significant for immunocompromised patients.
- - This review discusses recent advancements in LAMP technology, current research trends, and the challenges related to detecting Herpesviridae, stressing its importance for patient care.
Benznidazole prophylaxis: A game changer in preventing Chagas disease reactivation in transplant patients.
Transpl Infect Dis
October 2024
International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!